Classification: LONGEVITY-NEXUS | Confidence: MECHANISM REAL — LIFESPAN CLAIM UNPROVEN
There is a molecule inside every one of your cells that does two jobs at once: it carries energy and it regulates repair. It is called NAD+, and it declines steadily with age. Tie that decline to the enzymes that control DNA repair, and you have the entire premise of the modern anti-aging supplement industry in one sentence.
The Power Cell and Its Repair Crew
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme — a helper molecule the body makes from vitamin B3 and uses everywhere. It has two roles that matter here:
- It shuttles electrons in cellular energy production, the mitochondria’s fuel line.
- It is the fuel for sirtuins, a family of seven enzymes (SIRT1–7) that strip chemical tags off proteins, repairing DNA and controlling stress responses.
Sirtuins can do nothing without NAD+. No NAD+, no repair. And NAD+ levels fall as we age — in part because an enzyme called CD38, which degrades NAD+, rises with age. By late life, whole-tissue NAD+ can drop by half or more. The machinery is intact. The fuel is running low.
The Supplement Question
You cannot buy NAD+ in a pill; it does not survive digestion. So the market sells precursors — molecules the body converts into NAD+. The two that dominate:
- NR (nicotinamide riboside)
- NMN (nicotinamide mononucleotide)
Both are proven to raise NAD+ in human blood. The February 2026 Nature Metabolism head-to-head (65 healthy adults) found that NR and NMN at 1g/day roughly doubled circulating NAD+ after 14 days — while plain nicotinamide (Nam, the cheap form) only did so transiently. NR even shifted gut-microbe metabolites linked to lower inflammation.
Here Is Where the Hype Stalls
Raising NAD+ is measured and real. The gap is what follows:
- Small human trials report modest gains: improved muscle insulin sensitivity, better blood flow, some subjective energy — and one 90-day NMN study in men 45–60 reported telomere lengthening.
- But no trial has shown NAD+ boosting extends human life, or reliably reverses aging.
- In mice, overexpressing SIRT1 alone did not extend lifespan on a normal diet; it improved health and reduced tumors, but not longevity.
- There are early, unresolved questions about whether persistently high NAD+ could feed cancer cells, which also use the fuel.
The honest summary of the peer-reviewed record: NAD+ precursors are safe in the short term and reliably raise NAD+. Everything beyond that is extrapolation from mice and mechanism.
The Technical Debt Reading
Think of NAD+ as the system’s remaining battery. Every cell ships with a repair daemon (the sirtuins) that needs that battery. Aging, in this model, is not a failure of the repair code — it is a power shortage: the process that refills the battery (NAMPT) downregulates and the consumer (CD38) upregulates, and the whole repair layer quietly goes under-powered.
That is a clean, testable, simulation-native story: the hardware is fine, the supply chain degraded. Restoring the supply chain is, in principle, a software fix. The supplements achieve the first part for certain. Whether the downstream repair actually extends lifespan is the experiment the next decade is running.